Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities

Seminars in Cancer Biology
Wei WangXin Wang

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Similar to many other malignancies, CRC is a heterogeneous disease, making it a clinical challenge for optimization of treatment modalities in reducing the morbidity and mortality associated with this disease. A more precise understanding of the biological properties that distinguish patients with colorectal tumors, especially in terms of their clinical features, is a key requirement towards a more robust, targeted-drug design, and implementation of individualized therapies. In the recent decades, extensive studies have reported distinct CRC subtypes, with a mutation-centered view of tumor heterogeneity. However, more recently, the paradigm has shifted towards transcriptome-based classifications, represented by six independent CRC taxonomies. In 2015, the colorectal cancer subtyping consortium reported the identification of four consensus molecular subtypes (CMSs), providing thus far the most robust classification system for CRC. In this review, we summarize the historical timeline of CRC classification approaches; discuss their salient features and potential limitations that may require further refinement in near future. In other words, in...Continue Reading

Citations

Jul 9, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ana María WielandtFrancisco López-Köstner
Jul 14, 2020·International Journal of Cancer. Journal International Du Cancer·Takatoshi MatsuyamaAjay Goel
Jul 11, 2020·Chinese Medical Journal·Deng-Bo Ji, Ai-Wen Wu
Aug 21, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chen LiHongchang Gao
Sep 19, 2019·World Journal of Clinical Cases·Hui SongYong-Xiang Zhao
Mar 19, 2020·International Journal of Molecular Sciences·Paulina StokłosaChristine Peinelt
Aug 23, 2020·Chinese Medical Journal·Deng-Bo Ji, Ai-Wen Wu
Dec 6, 2019·Frontiers in Oncology·Valeria MaffeisRocco Cappellesso
Nov 30, 2019·BMC Cancer·Rachel V PurcellFrancis A Frizelle
Sep 24, 2020·Journal of Experimental & Clinical Cancer Research : CR·Hang-Ping YaoMing-Hai Wang
Apr 3, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raju KandimallaAjay Goel
Dec 22, 2020·Frontiers in Oncology·Meng ZhangQiu Zhao
Jan 21, 2021·Biomarkers in Medicine·John C FlickingerScott A Waldman
Oct 30, 2020·Journal of Inflammation Research·Qian HuangRui Zhu
Jan 6, 2021·Cells·Crescenzo MassaroCarmela Dell'Aversana
Mar 7, 2021·International Journal of Molecular Sciences·Rhynelle S DmelloAshwini L Chand
Feb 27, 2021·Clinical and Translational Medicine·Shaikha AlMusawiAbdolrahman S Nateri
Mar 12, 2021·Cell Communication and Signaling : CCS·Camille Ternet, Christina Kiel
Apr 9, 2021·Journal of Biomedical Science·Yu-Chen S H YangKuan Wang
Oct 2, 2021·Hepatology International·Gayatri RamakrishnaNirupma Trehanpati
Aug 21, 2021·Cancer Immunology Research·Momeneh ForoutanNicholas D Huntington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.